piracetam has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Piracetam has been described to improve neuroleptic-induced acute extrapyramidal syndrome where a central dopaminergic hyperactivity is implicated." | 2.65 | Effect of piracetam in Huntington's chorea. ( Destée, A; Petit, H; Warot, P, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zesiewicz, TA | 1 |
| Sullivan, KL | 1 |
| Hauser, RA | 1 |
| Sanchez-Ramos, J | 1 |
| Destée, A | 1 |
| Petit, H | 1 |
| Warot, P | 1 |
| Mateo, D | 1 |
| Giménez-Roldán, S | 1 |
2 trials available for piracetam and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Effect of piracetam in Huntington's chorea.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Huntington Disease; Injections, Intravenous; | 1984 |
[The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
Topics: Adult; Double-Blind Method; Female; Humans; Huntington Disease; Injections, Intravenous; Male; Middl | 1996 |
1 other study available for piracetam and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hun | 2006 |